BARR's ATTEMPT TO FORCE FASTER ANDA REVIEWS DENIED BY APPELLATE COURT; FDA IS "SLUGGISH," COURT FINDS, BUT EXPEDITING BARR's ANDAs UNFAIR TO OTHER FIRMS
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".